Navigation Links
Eurocine Vaccines Strengthens the Organization for Further Development
Date:4/7/2017

STOCKHOLM, April 7, 2017 /PRNewswire/ -- Eurocine Vaccines strengthens the organization with necessary competence, not only to prepare for further development of its first product, the nasal influenza vaccine candidate Immunose™ FLU, but also for further development of a pipeline of other vaccines based on the patented technology platform Endocine™.

"In parallel with finalizing the analyses and evaluation of the current study, we now prepare for the next steps of development. Reinforcing the organization with Sandra Jeldes Granstrand, a senior and experienced Project Leader of CMC[1], supports our ambitious strategy and rapid development ahead", said CSO Anna-Karin Maltais.

Simultaneously, CSO Anna-Karin Maltais is appointed Vice President Research and Development.

"This emphasizes our positive ambitions as we continue building value", said CEO Hans Arwidsson and continued "Ensuring that the next influenza season can be well used for further development, opens for a shorter way to market, to the benefit of patients and partners."

Results from the ongoing clinical study are expected in June/July 2017.

More information about the study can be found at www.clinicaltrials.gov.

[1] Chemistry Manufacturing and Control

CONTACT:
CEO of Eurocine Vaccines AB
hans.arwidsson@eurocine-vaccines.com  
+46-70-634-0171

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/eurocine-vaccines/r/eurocine-vaccines-strengthens-the-organization-for-further-development,c2235009

The following files are available for download:

http://mb.cision.com/Main/11552/2235009/654837.pdf

Se news release

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eurocine-vaccines-strengthens-the-organization-for-further-development-300436536.html


'/>"/>
SOURCE Eurocine Vaccines
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Animal Vaccines Market Expected to Reach $9,159 Million by 2022 - Allied Market Research
2. New Access to Vaccines Index Reveals First Landscape of Vaccine Company Actions to Improve Immunisation Coverage
3. Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014 - 2025
4. Global Influenza Vaccines - World Industry Market Outlook 2017-2027
5. Research and Markets - Global Travel Vaccines Market 2016-2020: Market Growth at CAGR of 6.83% - Growing Demand Among Travelers / Additional Age Group Approval / Inclusion in NIP
6. Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
7. Global Influenza Vaccines Market and Forecast to 2021: North America Accounted for 50% of the $5 Billion Market in 2015 - Research and Markets
8. Research and Markets - Global H1N1 Vaccines Market Analysis 2016-2025 - Trends, Technologies & Opportunities Report 2016-2025 - Vendors: Novartis, Zydus Cadila, Merck
9. Vaccines a 28 Billion-Dollar Market, Kalorama Information Study Finds
10. Kalorama: After Allergan Merger Halt, Vaccines a Focus for Pfizer
11. Profectus and Vyriad Form Global Collaboration to Develop Oncolytic Recombinant VSV (rVSV) Vaccines for Cancer Immunotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2018)... , ... August 10, 2018 , ... US Capital ... following a $2 million seed funding round. Carepoynt is an emerging leader in the ... center of a more rewarding and engaging healthcare ecosystem. , Headquartered in San Francisco, ...
(Date:8/9/2018)... ... 2018 , ... Autism is a developmental disorder affecting more than 3.5 million ... 1 in 68 people have the disorder), chances are you know someone on the ... child with autism methods of communication and tactics to interact with others. These options ...
(Date:8/7/2018)... ... 07, 2018 , ... Commissioner Gottlieb’s FDA:, Analysis of First Year and a ... ET, http://www.fdanews.com/commissionergottliebsfda , Under Commissioner Scott Gottlieb, changes at the FDA ... may have gotten hurt. , And Gottlieb is just getting started. , Mark the ...
Breaking Medicine Technology:
(Date:8/14/2018)... (PRWEB) , ... August 14, 2018 , ... Ross A. ... generation of freezing fat, at Clevens Face and Body Specialists. Dr. Clevens is known ... patients at his Melbourne and Merritt Island offices. Along with his associate, Amy Simon, ...
(Date:8/11/2018)... , ... August 10, 2018 , ... ... leader in Gout Relief. , What is gout? This painful, persistent condition originates ... a result of high levels of uric acid. Other contributing factors may be ...
(Date:8/11/2018)... Ga. (PRWEB) , ... August 10, 2018 , ... ... is known for providing innovative procedures to metro Atlanta. Drs. Brent Sharpe and ... at Northeast Georgia Medical Center in Braselton. , On June 27, the physicians ...
(Date:8/9/2018)... (PRWEB) , ... August 09, 2018 , ... ... not realize their implants have ruptured, according to cross-referenced data from The American ... and silicone gel implant rupture rates monitored by the FDA. As an MRI ...
(Date:8/9/2018)... ... August 09, 2018 , ... Balboa Horizons, ... new verification process that substance abuse providers must pass in order to advertise ... reach more people to help.” , Helping people is what Balboa Horizons ...
Breaking Medicine News(10 mins):